PostersISBT2006PostersTOPIC 02.2TOPIC 02.3The posters areon display fromMonday - ThursdayP-291 EVALUATION OF THE SENSITIVITY OF THE DIRECT ANTIGLOBULINTEST (DAT) BY THE ROUTINE SEROLOGICAL TUBE TEST (DAT-T) AND BYTHE MICROCOLUMN GEL TEST (DAT-G) FOR WARM-TYPE AUTO-IMMUNEHAEMOLYTIC ANAEMIA (AIHA) DIAGNOSTICSP-300 ANTI-M IMMUNIZATION: A POSSIBLY UNDERDIAGNOSEDCAUSE OF FETAL HEMOLYTIC ANEMIA AND INTRAUTERINE DEATHA. Wikman, A. Edner, G. Gryfelt, B. Jonnson, J.I. Henter (Karolinska University Hospital,Stockholm, Sweden)E.K. Klausa, S.B. Bochenek, A.M. Misiaszek (Regional Centre of <strong>Transfusion</strong> Medicine,Wroclaw, Poland)P-292 PREDICTIVE VALUE AND SENSITIVITY OF FIRST TRIMESTERSCREENING FOR IRREGULAR ERYTHROCYTE ANTIBODIES TO DETECTNON-RHESUS-D-IEA-MEDIATED HAEMOLYTIC DISEASE OF THENEWBORN IN THE NETHERLANDSJ.M. Koelewijn, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel, M. de Haas (SanquinP-301 THE ASSOCIATION OF FCGAMMA RECEPTOR IIA (CD32)POLYMOPHISM AND IGG SUBCLASS CONCENTRATION IN MATERNALSERUM IN ABO HEAMOLYTIC DISEASE OF NEWBORNY. Zhang, M. Liu, S. Liu (<strong>Blood</strong> Reseach Lab, Xi'an, China)Topic 02.3.104Research and Landsteiner Lab, Amsterdam, Netherlands)P-293 RISK FACTORS FOR RHESUS-D-IMMUNIZATION DESPITE POST-AND ANTENATAL ANTI-D-PROPHYLAXISJ.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel(Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands)P-294 AETIOLOGICAL FACTORS RELATED TO A POSITIVE DIRECTANTIGLOBULIN TEST (DAT) IN HIV INFECTED PATIENTSM. Lai, G. D'Onofrio, E. Visconti, E. Tamburrini, R. Cauda, G. Leone (Catholic UniversityImmunohematology Lab, Roma, Italy)P-295 LOWER HEMOGLOBIN LEVELS IN DAT POSITIVE HIV POSITIVEPATIENTS, ITS RELATIONSHIP WITH THE AGGLUTINATON STRENGHTSAND DIFFERENCES IN THE CLINICAL STAGESM. Lai, E. Visconti, G. D'Onofrio, E. Tamburrini, R. Cauda, G. Leone (Catholic UniversityImmunohematology Lab, Roma, Italy)P-298 A FAMILY OF HEMOLYTIC DISEASE OF THE NEWBORN FOR TWOGENERATIONS POTENTIALLY DUE TO ANTI-KGRed Cells - Antigen ModificationP-302 ANIMAL TRIALS OF MPEG MODIFIED RED BLOOD CELLSY. Qiu (Beijing Red Cross <strong>Blood</strong> Center, Beijing, China)P-303 EFFECTS OF SYNTHETIC POLYCATIONS ON ERYTHROCYTEMEMBRANE ANALYZED BY OPTICAL METHODSD. Riquelme, P. Grandfils, B. Fontana, M. Alessi, R. Valverde, G. Foresto, F. Relancio, F. Stoltz,A. Dumas (Fac. de Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina)P-304 ABNORMAL GLYCOSILATION OF ABH ANTIGENS IN HUMAN SPERMAND ITS RELATIOSHIP WITH DNA DAMAGE ASSESED BY (TDT- MEDIATED-DUTP-NICK END LABELING) TUNEL ASSAY IN INFERTILE MENA.S. Brufman, Ch. Chaingam, E.A. Solis, E.G. Orellano (National University of Rosario,Rosario, Argentina)P-305 THE CA19-9 ANTIGEN AND THE LEWIS STATUS OF PATIENTSWITH RENAL PELVIS DILATATIONG Koritsiadis (Athens University, Laiko Gnrl Hospital, Athens, Greece)105J. Takahashi, S. Kubo, H. Takahashi, M. Hirashima, T. Ezaki, K. Kimura, M. Tsuzi, T. Nakade,M. Horie, Y. Tomorari, H. Matsukura, F. Hirayama, K. Tsubaki, H. Minowa, Y. Tani, H. Shibata(Japanese Red Cross Osaka <strong>Blood</strong> Center, Osaka, Japan)P-299 GRAFT VERSUS HOST ANTI-RH(D) FOLLOWING RH-INCOMPATIBLEORTOTOPTIC LIVER TRANSPLANTATION (OLT): A CASE REPORTD. Venturelli, M. Masetti, L. Bensi, M.G. Baldini, G. Gerunda, M. de Palma (AziendaPoliclinico, Modena, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
PostersISBT2006PostersTOPIC 02.4The posters areon display fromMonday - ThursdayPOSTERS106Topic 02.4.Red Cells - <strong>Transfusion</strong>P-306 A FORTUITOUS BENEFIT OF RED BLOOD CELL EXCHANGE INTREATMENT OF A CHILD WITH ACUTE CHEST SYNDROMEC.F.M. Danielson, M. Heiney, W. Jackson, M. Skipworth, A. Miguel, L.J. McCarthy(Wishard Memorial Hospital, Indianapolis, United States of America)P-307 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303RBC FOR PATHOGEN INACTIVATION IN THREE DIFFERENT ADDITIVESOLUTIONS MAINTAINS RBC FUNCTIONA. Erickson, M.A. Schott, V.A. Lee, G.M. Castro, T. Peterson, A. North (Cerus Corporation,Concord, United States of America)P-308 HYPERHEMOLYSIS SYNDROMEV. Fakitsa, M. Papakonstantino, A. Flangini, F. Drini, G. Lyrakos, K. Maltezis, P. Stasinopoulou,L. Haliou, E. Erotokritou, K. Sofroniadou, M. Drosou (District General Hospital of Nikea,Athens, Greece)P-309 RETROSPECTIVE ANALYSIS OF TRANSFUSION RATE INHIP FRACTURE SURGERYV. Fakitsa, K. Maltezis, M. Papakonstantinou, J. Maniakis, T. Micha, E. Sotiropoulou,A. Flangini, F. Drini, N. Prevezas (District General Hospital of Nikea, Athens, Greece)P-314 THE IMPLEMENTATION OF RESTRICTIVE STRATEGY FOR PRBCSTRANSFUSION IN TREATMENT OF CARDIAC SURGERY PATIENTSE. Ambarkova Vilarova, M.Z. Mitrev, M. Blagoevska, C.A. Crvenpanova (Special Hospital <strong>for</strong>Cardiosurgery, Skopje, Macedonia)P-315 IMPROVING BLOOD TRANSFUSION PRACTICE IN ADISTRICT GENERAL MATERNITY UNITR. Mudenha, R. Lindsay, V. Rodie, A. Todd, A.J. Thomson (Royal Alexandra Hospital,Glasgow, United Kingdom)P-316 HAEMOVIGILANCE: DETECTION OF ADVERSE REACTIONSASSOCIATED WITH BLOOD TRANSFUSIONZ. Cermakova (Faculty Hospital, Ostrava, Czech Republic)P-317 A FATAL CLINICAL DILEMMA MIMICKING AN INTRAVASCULARHAEMOLYTIC TRANSFUSION REACTIONR. Sinha (Singh), D. Roxby (Flinders Medical Centre, Adelaide, Australia)P-318 TRANSFUSED BLOOD COMPONENTS VERSUS THE RESERVEDFOR SURGICAL PATIENTSS. Ortakovska, M. Balamovski, T. Timova, M. Blagoevska, R. Grubovic (General Hospital,Gevgelija, Gevgelija, Macedonia)P-319 BLOOD TRANSFUSION PRACTICE-PUBLIC VERSUS PRIVATE HOSPITALS107P-310 ERYTHROCYTAIRE CHARGE SURFACE PROPERTIES DURING STORAGEP. Foresto, N. Lebensohn, M. D'Arrigo, J. Valverde (Fac. Cs. Bioquímias y Farmacéuticas -UNR, Rosario, Argentina)P-311 THE ESTABLISHMENT OF RED CELL BLOOD TYPE DATA BANK FORMN, P, KIDD, DUFFY AND LEWIS ANTIGEN SYSTEMSM. Liu, S. Ye, J. Qi (<strong>Blood</strong> Center of Shaanxi Province China, Xi`an, China)P-312 EVALUATION OF PRODUCT QUALITY AND DONOR SAFETYFOLLOWING DOUBLE UNIT RED CELL APHERESIS USING THE ALYXCOMPONENT COLLECTION SYSTEMA. Sen, K. Chatterjee (Armed Forces <strong>Transfusion</strong> Centre, New Delhi, India)P-313 EDUCATION OF NURSES IN TRANSFUSION THERAPYD. Sovic (University Hospital, Zagreb, Croatia)T.M. Makarovska-Bojadzieva, M. Blagoevska, J. Samonikov-Tosevska, R. Grubovik(National Institute of <strong>Blood</strong> <strong>Transfusion</strong>, Skopje, Macedonia)P-321 ONTARIO NURSE TRANSFUSION COORDINATORS (ONTRAC):A PROVINCIAL BLOOD CONSERVATION PROGRAMJ. Freedman, K. Luke, M. Escobar, M.B. Garvey, J.A. Chiavetta (St Michael's Hospital,Toronto, Ontario, Canada)P-322 RED CELL TRANSFUSION IN POLAND - A NATIONAL SURVEYA. Rosiek, A. Dzieciatkowska, M. Letowska (Institute of Hematology, Warsaw, Poland)P-323 COMPARISON OF OPERATOR PROCESSES FOR PRETRANSFUSIONTESTING ON THE ORTHO AUTOVUE INNOVA, GALILEO, AND CLASSICID-GEL STATION USING FAILURE MODES AND EFFECTS ANALYSISF. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale,United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
- Page 24 and 25:
XXIX th International Congressof th
- Page 26 and 27: ISBT2006WORDS OF WELCOME5It is with
- Page 28 and 29: ISBT20068ORGANISATION - COMMITTEESO
- Page 30 and 31: Programme per DayISBT2006Programme
- Page 32 and 33: ISBT2006Programme per DayTHURSDAY,
- Page 34 and 35: Sunday, 3 SeptemberISBT2006Sunday,
- Page 36 and 37: Sunday, 3 SeptemberISBT2006Monday,
- Page 38 and 39: Monday, 4 SeptemberISBT2006Monday,
- Page 40 and 41: Monday, 4 SeptemberISBT2006Monday,
- Page 42 and 43: Monday, 4 SeptemberISBT2006Monday,
- Page 44 and 45: Monday, 4 SeptemberISBT2006Tuesday,
- Page 46 and 47: Tuesday, September 5ISBT2006Wednesd
- Page 48 and 49: Wednesday, 6 SeptemberISBT2006Wedne
- Page 50 and 51: Wednesday, 6 SeptemberISBT2006Wedne
- Page 52 and 53: Wednesday, 6 SeptemberISBT2006Wedne
- Page 54 and 55: Wednesday, 6 SeptemberISBT2006Thurs
- Page 56 and 57: Thursday, 7 SeptemberISBT2006Thursd
- Page 58 and 59: PostersISBT2006PostersTOPIC 01.1The
- Page 60 and 61: PostersISBT2006PostersTOPIC 01.2TOP
- Page 62 and 63: PostersISBT2006PostersTOPIC 01.2TOP
- Page 64 and 65: PostersISBT2006PostersTOPIC 01.5The
- Page 66 and 67: PostersISBT2006PostersTOPIC 01.6TOP
- Page 68 and 69: PostersISBT2006PostersTOPIC 01.8The
- Page 70 and 71: PostersISBT2006PostersTOPIC 02.1TOP
- Page 72 and 73: PostersISBT2006PostersTOPIC 02.1TOP
- Page 74 and 75: PostersISBT2006PostersTOPIC 02.1TOP
- Page 78 and 79: PostersISBT2006PostersTOPIC 02.4TOP
- Page 80 and 81: PostersISBT2006PostersTOPIC 03.2The
- Page 82 and 83: PostersISBT2006PostersTOPIC 04.3The
- Page 84 and 85: PostersISBT2006PostersTOPIC 05.2The
- Page 86 and 87: PostersISBT2006PostersTOPIC 05.2TOP
- Page 88 and 89: PostersISBT2006PostersTOPIC 07.2The
- Page 90 and 91: PostersISBT2006PostersTOPIC 08.1-3T
- Page 92 and 93: PostersISBT2006PostersTOPIC 09.2TOP
- Page 94 and 95: PostersISBT2006PostersTOPIC 10.1TOP
- Page 96 and 97: PostersISBT2006PostersTOPIC 11.1The
- Page 98 and 99: PostersISBT2006PostersTOPIC 11.4The
- Page 100 and 101: PostersISBT2006PostersTOPIC 13.0TOP
- Page 102 and 103: PostersISBT2006PostersTOPIC 15.0TOP
- Page 104 and 105: ISBT Business MeetingsISBT2006Key I
- Page 106 and 107: Key InformationISBT2006Key Informat
- Page 108 and 109: Scientific InformationISBT2006Scien
- Page 110 and 111: Registration InformationISBT2006Soc
- Page 112 and 113: ISBT2006FLOORPLANGROUND FLOORFLOORP
- Page 114 and 115: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 116 and 117: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 118 and 119: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 120 and 121: ISBT2006LIST OF EXHIBITORSin terms
- Page 122 and 123: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 124 and 125: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 126 and 127:
ISBT2006LIST OF EXHIBITORS59 Cape C
- Page 128 and 129:
ISBT2006MAP OF CAPE TOWNSPEAKERS IN
- Page 130 and 131:
International Society ofBlood Trans
- Page 132:
ISBT2006NOTES216INTERNATIONAL SOCIE